Literature DB >> 18771242

Cycloartane triterpenoids from Astragalus bicuspis.

M Iqbal Choudhary1, Saleem Jan, Ahmed Abbaskhan, Syed Ghulam Musharraf, Samina A Sattar.   

Abstract

Three new cycloartane glycosides have been isolated from Astragalus bicuspis. They were identified as 6alpha-hydroxy-3-O-beta-xylopyranosyloxy-24,25,26,27-tetranor-9,19-cyclolanosta-16,23-lactone (1), 6alpha-hydroxy-23-methoxy-16beta,23(R)-epoxy-24,25,26,27-tetranor-9,19-cyclolanosta-3-O-beta-xyloside (2), and 23(R),24(S),25(R),26(S)-16beta/23,23/26,24/25-triepoxy-6alpha,26-dihydroxy-9,19-cyclolanosta-3-O-beta-xyloside (3), on the basis of their spectroscopic data. Two known cycloartane derivatives, 4 and 5, were also obtained from this plant. Compounds 2-5 were tested for leishmanicidal activity against Leishmania major promastigotes and for cytotoxicity against 3T3 cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771242     DOI: 10.1021/np800161j

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Kleinhospitine E and Cycloartane Triterpenoids from Kleinhovia hospita.

Authors:  Abdul Rahim; Yohei Saito; Katsunori Miyake; Masuo Goto; Chin-Ho Chen; Gemini Alam; Susan Morris-Natschke; Kuo-Hsiung Lee; Kyoko Nakagawa-Goto
Journal:  J Nat Prod       Date:  2018-07-16       Impact factor: 4.050

2.  Biological screening of euphorbia aellenii.

Authors:  Abdul Majid Ayatollahi; Mustafa Ghanadian; Suleiman Afsharypuor; Sadia Siddiq; Seyed Muhammad Pour-Hosseini
Journal:  Iran J Pharm Res       Date:  2010       Impact factor: 1.696

3.  Chemical constituents from Licania cruegeriana and their cardiovascular and antiplatelet effects.

Authors:  Omar Estrada; Whendy Contreras; Giovana Acha; Eva Lucena; Whitney Venturini; Alfonso Cardozo; Claudia Alvarado-Castillo
Journal:  Molecules       Date:  2014-12-17       Impact factor: 4.411

4.  A Study on the Mechanism of Milkvetch Root in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.

Authors:  Chunli Piao; Qi Zhang; Li Wang; Cheng Tang; Naiwen Zhang; Fengmei Lian; Xiaolin Tong
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-31       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.